Overview

A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2010-03-26
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the pharmacodynamic profile (blood glucose and urinary glucose excursion) of ASP1941 in patients with type 2 diabetes mellitus. Safety, tolerability and pharmacokinetics are also evaluated.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin